CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$492,000
-9.6%
144,6540.0%0.00%0.0%
Q2 2018$544,000
-2.5%
144,654
+6.1%
0.00%0.0%
Q1 2018$558,000
-14.9%
136,394
-3.4%
0.00%0.0%
Q4 2017$656,000
-35.4%
141,175
-1.4%
0.00%
-50.0%
Q3 2017$1,016,000
-3.1%
143,144
-1.3%
0.00%0.0%
Q2 2017$1,048,000
+9.4%
144,958
-6.8%
0.00%0.0%
Q1 2017$958,000
+0.4%
155,458
-4.5%
0.00%0.0%
Q4 2016$954,000
+7.6%
162,758
-2.6%
0.00%0.0%
Q3 2016$887,000
-19.1%
167,058
+0.9%
0.00%0.0%
Q2 2016$1,096,000
+6.9%
165,558
-24.6%
0.00%0.0%
Q1 2016$1,025,000
+5.7%
219,429
+14.3%
0.00%0.0%
Q4 2015$970,000
+46.1%
191,985
+1.8%
0.00%0.0%
Q3 2015$664,000
-64.8%
188,605
-0.3%
0.00%
-60.0%
Q2 2015$1,888,000
-19.9%
189,205
+2.2%
0.01%
-16.7%
Q1 2015$2,358,000
-2.2%
185,219
+8.7%
0.01%0.0%
Q4 2014$2,411,000
+3.9%
170,419
+1.0%
0.01%0.0%
Q3 2014$2,321,000
-9.6%
168,797
+1.1%
0.01%0.0%
Q2 2014$2,568,000
-7.1%
166,939
+3.0%
0.01%
-14.3%
Q1 2014$2,763,000
+44.2%
162,139
+9.6%
0.01%
+40.0%
Q4 2013$1,916,000
+29.0%
147,939
+0.6%
0.01%
+25.0%
Q3 2013$1,485,000
+39.6%
147,039
+3.3%
0.00%
+33.3%
Q2 2013$1,064,000
+6.7%
142,400
+0.6%
0.00%0.0%
Q1 2013$997,000141,5500.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders